Rheumatoid Arthritis Treatment

Treatment targets include suppressing inflammatory activity and preventing bone destruction through suppressing the dysregulated immune response.


In addition to clinical examination with identification of the affected joints, imaging techniques (sonography, X-ray, magnetic resonance imaging) are available to evaluate inflammation and  structural damage. Differentiation from other inflammatory rheumatic diseases is important. Rheumatoid factors and anti-CCP antibodies in the blood are important diagnostic markers. The assessment of possible organ involvement (skin, heart, vessels, lung, eye, nervous system) is important.


Systemic steroids are used as a bridge until slower acting disease modifying anti-rheumatic drugs (DMARDs) become effective. The latter replace the long-term use of steroids and can favourably influence the course of the disease. These include conventional synthetic, targeted synthetic and biologic DMARDs. The early start of a DMARD therapy is crucial for the prevention of joint destruction. Non-pharmacological measures complement the therapeutic principles.


Our team cooperates in the field of rheumatoid arthritis within the Swiss Clinical Quality Management Program (SCQM).

For patients

As a patient, you cannot register directly for a consultation. Please have your primary care physician or specialist refer you. If you have any questions, please use our contact form.

Contact form

For referrer

Please refer your patients online.

Tel. +41 44 255 26 87
Patient online registration

Responsible Department